Next Sequence®
Šárka Sirůčková is an experienced professional in investor relations and venture capital, currently serving as an Investor Relations Partner and Venture Associate at Next Sequence® since May 2023, where responsibilities include raising a $25M fund and managing investor relations. Prior experience includes working as an HTA Consultant at Symmetron from November 2021 to June 2024, where Šárka focused on market access strategies for pharmaceuticals, as well as project management and client relations. Earlier roles include project coordination and communications at Symmetron, where significant contributions resulted in revenue growth and enhanced engagement metrics. Additional experience encompasses consulting for a stealth biotech startup, operational support at Bontia, and an internship at the Edinburgh University Sports Union, alongside comprehensive education in bioscience entrepreneurship and biotechnology from UCL and The University of Edinburgh.
This person is not in any teams
This person is not in any offices
Next Sequence®
1 followers
Next Sequence accelerate and invest globally in start-ups from the #TechBio ecosystem through a 6-12 accelerator program taking them from 0 to 1 in leveraging AI and Quantum Computing. Our mission is to contribute to the development of the most disruptive companies who want to enable humanity to face up to its next challenges as a species, from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.